Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: A southwest oncology group study

Gary E. Goodman, John Crowley, Robert B. Livingston, Saul E. Rivkin, Kathy Albain, John H. McCulloch

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint Dive into the research topics of 'Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: A southwest oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences